Evonik launches MaxiPure Polysorbate 80 for injectable drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
Relonchem receives marketing authorization for Moxonidine tablets
Prolia is a prescription medicine used to treat osteoporosis in women
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Agency initiates safety label change and notifies physicians of possible link
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
Subscribe To Our Newsletter & Stay Updated